Acquisitions (Tables)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

2010 Acquisitions [Member]

Dec. 31, 2011

2011 Acquisitions [Member]

Subsequent Event [Line Items]

Fair Values Of The Assets Acquired And Liabilities

Total	2011			2010			2009
Accounts receivable	$	859.5		$	178.7		$	70.6
Inventory		812.4			171.2			42.8
Property, plant and equipment		1,042.1			84.8			39.0
Goodwill		4,164.7			1,157.8			422.9
Other intangible assets, primarily trade names, customer relationships and patents		2,772.4			870.9			224.7
In-process research and development		143.0			26.5			1.0
Accounts payable		(278.2	)		(59.6	)		(35.1	)
Other assets and liabilities, net		(1,662.9	)		(238.4	)		(62.1	)
Assumed debt		(1,640.4	)		(0.9	)		(0.3	)
Non-controlling interest acquired		(1.8	)		(61.3	)		—
Net cash consideration	$	6,210.8		$	2,129.7		$	703.5

	AB Sciex & Molecular Devices			Others			Total
Accounts receivable	$	102.7		$	76.0		$	178.7
Inventory		104.3			66.9			171.2
Property, plant and equipment		54.5			30.3			84.8
Goodwill		496.9			660.9			1,157.8
Other intangible assets, primarily customer relationships, trade names and patents		342.0			528.9			870.9
In-process research and development		7.4			19.1			26.5
Accounts payable		(37.9	)		(21.7	)		(59.6	)
Other assets and liabilities, net		(30.7	)		(207.7	)		(238.4	)
Assumed debt		(0.9	)		—			(0.9	)
Attributable to non-controlling interest		—			(61.3	)		(61.3	)
Net cash consideration	$	1,038.3		$	1,091.4		$	2,129.7

	Beckman Coulter			Others			Total
Accounts receivable	$	783.3		$	76.2		$	859.5
Inventory		774.0			38.4			812.4
Property, plant and equipment		1,036.2			5.9			1,042.1
Goodwill		3,745.8			418.9			4,164.7
Other intangible assets, primarily trade names, customer relationships and patents		2,518.0			254.4			2,772.4
In-process research and development		143.0			—			143.0
Accounts payable		(257.3	)		(20.9	)		(278.2	)
Other assets and liabilities, net		(1,561.0	)		(101.9	)		(1,662.9	)
Assumed debt		(1,640.4	)		—			(1,640.4	)
Non-controlling interest acquired		—			(1.8	)		(1.8	)
Net cash consideration	$	5,541.6		$	669.2		$	6,210.8

Results Of Operations If Acquisition Was Consummated

	2011		2010
Sales	$	17,994.8	$	16,866.5
Net earnings from continuing operations	$	2,013.2	$	1,860.9
Diluted earnings per share from continuing operations	$	2.84	$	2.66